Fucoidan inhibited the progression of gastric cancer by upregulating the CLEC-2 level in gastric cancer cells through the transcription factor caudal type homeobox transcription factor 2, an important regulator of gut homeostasis [68]. Here, CLEC1B is linked to gastric cancer.